Loading clinical trials...
Loading clinical trials...
The study is prospectively initiated to: (1) evaluate the alterations in platelet function to aspirin therapy and the prevalence of aspirin resistance in patients with chronic kidney disease undergoin...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Collaborators
NCT04634916 · Kidney Disease, End-Stage, End-stage Renal Disease, and more
NCT06933472 · Hyperphosphatemia, Chronic Kidney Disease, Receiving Dialysis, and more
NCT07224763 · ESRD (End-Stage Renal Disease), Kidney Transplantation, and more
NCT07033260 · Intradialytic Hypotension, End-Stage Renal Disease Requiring Haemodialysis, and more
NCT05738525 · End-stage Renal Disease
Taipei Veterans General Hospital
Taipei
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions